arrow
M

Manu Pandey

University of Texas Health Science Center Houston
H指数:11
被引数:418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States

理解多样性:ASTCT-NMDP ACCESS计划对美国造血细胞移植与细胞治疗从业人员的一项调查

2025-09-270
PRE
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients

医师对造血细胞移植和细胞治疗的倡导:克服挑战以减少患者差异并改善预后

2025-09-260
PRE
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

髓源性抑制细胞线粒体适应性控制血液系统恶性肿瘤的化疗疗效

2024-03-308
OAAI
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms

基于venetoclax的组合在加速期和急变期骨髓增殖性肿瘤患者中的疗效和毒性的多中心评估

2021-10-2917
OA
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
2021-01-0469
OAAI